George Herron
Nephrology · Stockton, CANPI 1144217654
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,179 of the $3,569 with a category attached, or 89.1%. It is spread thinly across 22 manufacturers, the largest accounting for just 14.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2020 at $1,035 and has fallen 98.2% since, to $18 in 2024.
Across 178 payments — averaging $20.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$499
- Novo Nordisk$394
- Vifor Pharma, Inc.$379
- Fresenius USA Marketing, Inc.$357
- Akebia Therapeutics Inc$335
- Johnson & Johnson$276
- plus $1K from 16 others
What the payments were for
- Speaking & faculty fees$2006%
- Food & beverage$3,17989%
- Education$1905%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 22 | $499 |
| Novo Nordisk | 26 | $394 |
| Vifor Pharma, Inc. | 13 | $379 |
| Fresenius USA Marketing, Inc. | 16 | $357 |
| Akebia Therapeutics Inc | 19 | $335 |
| Johnson & Johnson | 17 | $276 |
| Amgen | 11 | $226 |
| OPKO Pharmaceuticals, LLC | 10 | $186 |
| Otsuka America Pharmaceutical, Inc. | 8 | $171 |
| Gilead | 6 | $164 |
| Sunovion Pharmaceuticals Inc. | 9 | $145 |
| Boehringer Ingelheim | 5 | $114 |
| Lilly USA, LLC | 4 | $81 |
| Amarin Pharma, Inc. | 3 | $62 |
| GSK | 2 | $47 |
| Aurinia Pharma U.S., Inc. | 1 | $26 |
| Acadia Pharmaceuticals Inc | 1 | $24 |
| Novartis | 1 | $19 |
| Nestle Healthcare Nutrition Inc. | 1 | $18 |
| Travere Therapeutics, Inc. | 1 | $18 |
| Sanofi-aventis U.S. LLC | 1 | $16 |
| Nxstage Medical, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Veltassa$200
How this compares
$3,569 in reported general payments places this provider in the 70th percentile of 1,341 nephrology providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Labetalol Hcl | 12 | $1,013 |
Paid to pharmacies, not to this prescriber.
Other nephrology in Stockton
- Anjay RastogiLos Angeles$2.2M
- Glenn ChertowStanford$2M
- Luis AlvarezPalo Alto$1.8M
- Jose MorfinSacramento$1M
- Rodolfo BatarseRancho Mirage$910K
- Vandana MathurWoodside$769K
- Yasir QaziOrange$618K
- Rafael VillicanaLoma Linda$610K
- Sunil PatelApple Valley$509K
- Suphamai BunnapradistLos Angeles$498K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.